All episodes

In this episode Diabetes Perspectives, Prof. Partha Kar, National Specialty Advisor for Diabetes with NHS England, shares how the UK became the first country in the world to offer universal access to continuous glucose monitors and hybrid closed-loop systems for people with type 1 diabetes.

Prof. Kar discusses the challenges of clinical inertia, the crucial role of patient advocacy, and how data-driven outcomes persuaded policymakers to invest in diabetes technology. He also offers lessons for healthcare leaders worldwide and explains why success isn’t just about funding but about listening to those living with the condition.

Join us for a practical,...

In this episode, Prof. Emma Ahlqvist (Lund University) and Prof. Matthias Blüher (University of Leipzig) join host Vivienne Parry to explore the future of type 2 diabetes. They unpack the shift from a one-size-fits-all approach to one that embraces stratified and personalised care.

From using machine learning to define diabetes subtypes to applying AI tools for screening, they share how new approaches could enable earlier diagnosis, better treatment choices, and improved outcomes. With obesity increasingly recognised as a chronic disease and not merely a lifestyle issue, they also discuss the need for broader access to therapies - and how stigma...

In this episode of Diabetes Insights, we’re talking about a topic that doesn’t get nearly enough attention in diabetes care: Sexual Health. Studies show that people with diabetes are twice as likely to experience sexual dysfunction, yet many patients and healthcare professionals struggle to discuss it openly.
Join host Vivienne Parry as she speaks with Dr. Aleksandra Uruska, a diabetologist from Poznań University of Medical Sciences, and Dr. Marieke Dewitte, a clinical psychologist and sexologist from Maastricht University.
Together, they explore the biological, psychological, and social factors affecting sexual health in diabetes, the importance of breaking the stigma, and how...

Could weight loss be the key to managing heart failure? In this episode of Diabetes Insights, we dive into the STEP-HFpEF trial, a groundbreaking study exploring the role of GLP-1 receptor agonists in heart failure with preserved ejection fraction (HFpEF).
Host Vivienne Parry speaks with Prof. Melanie Davies (University of Leicester), Prof. Mark Petrie (University of Glasgow), and Prof. Mikhail Kosiborod (Saint Luke’s Mid America Heart Institute, USA) about the link between obesity, diabetes, and HFpEF, and how weight management could transform heart failure treatment.
With trials already in motion to explore prevention, could we stop HFpEF before it starts?...

In this episode of Diabetes Insights, we explore the power of screening in type 1 diabetes and the potential for early intervention. Host Vivienne Parry speaks with EASD President, Prof. Chantal Mathieu and Prof. Annette Ziegler about groundbreaking research into detecting type 1 diabetes in its earliest stages.

With new disease-modifying therapies on the horizon, early screening is no longer just about preventing complications at diagnosis but it could delay the onset of diabetes and open doors to future treatments.

We discuss how registries, European-wide collaboration, and real-world screening initiatives are shaping the future of early detection, patient monitoring, and...

In this episode, we dive into the critical role of the European Diabetes Forum (EUDF) in shaping diabetes policy across Europe. Host Vivienne Parry speaks with Bart Torbeyns about why bringing together stakeholders - including patient associations, research institutions, healthcare professionals, and industry - is essential to influencing policy makers and improving access to diabetes care.

We discuss the importance of securing diabetes on the EU agenda, tackling the rising costs of diabetes, and addressing misconceptions around obesity and new therapeutics. With European elections reshaping healthcare priorities, how can the diabetes community push for action?

Join us for a compelling...

In this episode of Diabetes Insights, we dive into the latest findings from the FLOW Trial - a groundbreaking trial evaluating the impact of GLP-1 receptor agonists on chronic kidney disease (CKD). This discussion features expert insights from Dr. Peter Rossing, Dr. Richard Pratley and Dr. Katherine Tuttle. The results reveal a 24% reduction in kidney disease progression, an 18% decrease in major cardiovascular events, and a 20% drop in total mortality - findings that could reshape clinical practice. Tune in to explore how this research is transforming diabetes and kidney disease management.

In this episode of the EASDtv Podcast, we explore a cutting-edge approach to diabetes screening - using voice. Dr Guy Fagherazzi and Dr Abir Elbeji from the Luxembourg Institute of Health discuss their research into how AI-powered voice analysis can detect subtle vocal changes linked to type 2 diabetes.

With a growing global burden of undiagnosed diabetes, this technology could provide a scalable, non-invasive screening tool accessible via smartphones. How does it work? How accurate is it? And what does this mean for the future of diabetes care?

Tune in to find out how voice-based AI could change the landscape...

In this episode, we sit down with Prof. Juleen Zierath, recipient of the 2024 EASD-Novo Nordisk Foundation Diabetes Prize for Excellence. A former EASD President, Prof. Zierath shares insights from her pioneering research on the role of exercise in diabetes management, exploring how physical activity can improve glucose metabolism, insulin sensitivity, and overall metabolic health. She also discusses the impact of circadian rhythms on metabolism, the mysteries of insulin action, and the future of precision medicine in diabetes care.

The role of beta cells in diabetes is well established, but how important are the other cells within the islet network?
In this episode of Diabetes Insights, Prof. Mark Huising (University of California) and Prof. Guy Rutter (Imperial College London) dive into the intricate crosstalk between islet cells and its impact on insulin secretion and glucose regulation. They debate the influence of alpha and delta cells on beta cell function and explore whether these interactions could hold the key to better diabetes treatments.